BioFinland Member
Neurotar Ltd
Company name
Neurotar Ltd
Address
Viikinkaari 4, FI-00790 Helsinki
Telephone
358 9 428 344 56
Employees
1-9
Founded
2009
Contact person
Katja Karelina
CEO
Katja Karelina
Web site
Main categories
Preclinical CRO, Medical devices
Last updated
2 February 2023
Company profile
Neurotar offers in vivo two-photon and wide-field imaging of the mouse brain as a service to global CNS drug developers. Key applications include dendritic spine turnover, calcium imaging, microglia imaging, blood-brain barrier permeability, and trans-blood-brain barrier pharmacokinetics of large molecules. In vivo two-photon imaging allows studying the brain longitudinally with subcellular resolution while wide-field imaging elucidates the functioning of the neural networks. Neurotar is certified to work with scheduled compounds such as psychedelics.
In our second line of business, we commercialize innovative research tools (Mobile HomeCage® line of products) that enable basic research in live non-anesthetized mice. Mobile HomeCage® products eliminate the biases associated with the use of anesthetics. They allow combining high precision techniques (in vivo two-photon imaging, functional ultrasound imaging (fUS), in vivo electrophysiology, optogenetics) that require supreme stability with behavioral studies. More than 180 academic and industrial labs worldwide use the Mobile HomeCage® for brain research in awake mice.